Skip to main content
. 2021 Nov 6;20:154. doi: 10.1186/s12944-021-01580-z

Table 4.

ANGPTL3, ANGPTL4 and lipids levels of the study sample according to the number of involved vessels stenosis ≥ 50%

Variable The number of involved vessels stenosis (≥ 50%)
0-vessel 1-vessel ≥ 2-vessel F value P value
ANGPTL3, ng/mL 38.10 ± 50.54 40.21 ± 22.33 57.37 ± 38.24 37.708 < 0.001
ANGPTL4, ng/mL 669.73 ± 738.11 456.09 ± 286.90 445.31 ± 251.73 7.480 0.024
Triglycerides, mmol/L 1.65 ± 0.96 1.77 ± 1.18 1.47 ± 0.57 1.094 0.336
LDL-C, mmol/L 2.81 ± 0.84 2.69 ± 0.92 2.92 ± 1.01 0.905 0.406
HDL-C, mmol/L 1.11 ± 0.33 1.03 ± 0.28 1.02 ± 0.29 2.469 0.087
apoA-I, g/L 1.14 ± 0.20 1.10 ± 0.20 1.07 ± 0.24 1.624 0.200
apoB, g/L 0.91 ± 0.57 0.82 ± 0.24 0.85 ± 0.28 0.655 0.520
apoA-I/apoB 1.47 ± 0.44 1.50 ± 0.52 1.44 ± 0.59 0.106 0.900
apoE, mg/dL 4.51 ± 1.40 4.74 ± 2.62 4.15 ± 1.38 0.958 0.385
Lipoprotein(a), g/L 0.16 ± 0.18 0.14 ± 0.15 0.20 ± 0.20 1.844 0.160
FFA, mmol/L 0.47 ± 0.19 0.53 ± 0.23 0.53 ± 0.24 1.540 0.217

Values are expressed as mean ± standard deviation or percentage; ANGPTL angiopoietin-like proteins, LDL-C low-density lipoprotein-cholesterol, HDL-C high-density lipoprotein-cholesterol, apo apolipoprotein, FFA Free fatty acid